282 related articles for article (PubMed ID: 16573548)
1. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
Bladon J; Taylor PC
Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
Bladon J; Taylor PC
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
Bladon J; Taylor PC
J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease.
Di Renzo M; Rubegni P; Pasqui AL; Pompella G; De Aloe G; Sbano P; Cuccia A; Castagnini C; Auteri A; Laghi Pasini F; Fimiani M
Br J Dermatol; 2005 Jul; 153(1):59-65. PubMed ID: 16029327
[TBL] [Abstract][Full Text] [Related]
6. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
Bladon J; Taylor P
J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
[TBL] [Abstract][Full Text] [Related]
8. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
9. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
Darvay A; Salooja N; Russell-Jones R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Bladon J; Taylor P
Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
[TBL] [Abstract][Full Text] [Related]
11. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
Bladon J; Taylor PC
Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
16. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
17. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM; Gorgun G; Miller KB
Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]